SMO and pancreatic neoplasm: In pancreatic cancer therapy, combination of a SMO inhibitor, cyclopamine, and gemcitabine, a nucleotide analog, completely abrogate pancreatic cancer metastasis while also significantly reduce the size of the primary tumor [120].